ITP is associated with thrombocytopenia, due to immune platelet destruction.

 

OBJECTIVES

1.Review thrombocytopenia and the pathophysiology of ITP.

​

2.Discuss the diagnosis of ITP 

​

3.Outline first- line management 

​

4.Provide an overview of second- line treatment strategies

​

5.Highlight third-line agents and novel agents in development

-----

Presentation:

Cindy Neunert, MD MSCS

Associate Professor, Pediatrics

Columbia University Irving Medical Center

Date: November 11, 2021